We applaud Luxembourg for co-sponsoring the WHA Resolution on Rare Diseases alongside the Arab Republic of Egypt, Spain, Qatar, France, Malaysia, Chile, Panama, the Philippines, the State of Palestine, and Kuwait.
As negotiations on the resolution are ongoing, now more than ever, we call on all Member States to support or co-sponsor the WHA Resolution and the Global Action Plan on Rare Diseases ahead of the WHO Executive Board meeting (3–11 February 2025). Global action is necessary to ensure that rare diseases are recognized and prioritized in health systems worldwide.
Read the November 2024 Newsletter from Rare Diseases International
Not a subscriber yet? Sign up here
Read the October 2024 Newsletter from Rare Diseases International
Not a subscriber yet? Sign up here
RDI hosts side event at World Health Summit in Berlin
At the 2024 World Health Summit in Berlin, Rare Diseases International (RDI) hosted a side-event entitled “Why Prioritize Rare Diseases in Global Health Policy? Aligning with the World Health Assembly (WHA) Resolution on Rare Diseases”, on October 13th, 2024. Representatives from the Ministries of Health of Egypt, France, Spain, and Qatar participated alongside a diverse panel including 4 speakers with lived experience of rare diseases. The event was well attended with over 100 attendees over the course of the event, both in-person and on-line. You can read the event report here to see the event highlights. You can also watch the full event here. Amidst a very productive and insightful discussion, 3 principal takeaway messages emerged:
• A systems approach is needed: rare diseases must be integrated into health and financing systems as part of NCD and UHC frameworks. “Rare diseases should be driving UHC.”
• It is critical to look at the wider social and economic impacts of rare diseases. “When we are talking about rare diseases we are not just talking about the patients, we are talking about their families, their classmates, their workmates.”
• This is about political will: By co-sponsoring the resolution countries are putting rare diseases on the agenda at the highest level. “We know that implementation will be challenging but the rare diseases community has the expertise and we are ready more than ever.”
RDI is looking forward to continuing to support Egypt, Spain, Qatar, Malaysia, France, Panama, Chile, and more Member States to make the WHA Resolution on Rare Diseases a reality in 2025. You can find out more about the WHA Resolution initiative here.
Read the September 2024 Newsletter from Rare Diseases International
Not a subscriber yet? Sign up here
France joins Egypt, Qatar, Spain and Malaysia in co-sponsoring WHA resolution
During RDI’s webinar “Towards a World Health Assembly Resolution” on 30 August 2024, co-hosted by Egypt, Qatar and Spain, France announced that it will co-sponsor the #Resolution4Rare alongside four other member states.
The webinar demonstrated the growing momentum towards the Resolution, with over 300 attendees and the participation of 5 Ministries of Health, the World Health Organization, and RDI member and partner organizations from 7 countries on 4 continents.
See the highlights here:
The key takeaways from the webinar were clear:
- Rare diseases must be a global health priority, integrated into Universal Health Coverage, to ensure that no one is left behind
- The Resolution co-sponsors are aligned on the need for a Global Action Plan to address the complex needs of Persons Living with a Rare Disease (PLWRD)
Watch the full webinar here:
Read the August 2024 Newsletter from Rare Diseases International
Not a subscriber yet? Sign up here
New Council Officers Elected
We are pleased to announce the results of the recent RDI Council elections. The newly elected officers are as follows:
- Chair: Kirsten Johnson (Fragile X International)
- Secretary: Ritu Jain (DEBRA International)
- Treasurer: Yann Le Cam (EURORDIS – Rare Diseases Europe)
Kirsten, Ritu, and Yann will bring strong leadership and dedication to their respective roles, helping to advance RDI’s mission to be a strong common voice on behalf of Persons Living with a Rare Disease (PLWRD) around the world, to advocate for rare diseases as an international public health priority, and to represent RDI members and enhance their capacities at regional and national levels.
We would also like to extend our deepest gratitude to Durhane Wong-Rieger for her nearly 10 years of service to RDI as Council Chair. Under her leadership, RDI has grown significantly, championing the needs and rights of individuals with rare diseases globally. Her unwavering focus and tireless efforts have made a lasting impact on the organization and the community we serve.
Please join us in welcoming the new officers and in thanking Durhane for her decade of exemplary commitment and vision.
Read the July 2024 Newsletter from Rare Diseases International
Not a subscriber yet? Sign up here
Egypt Sponsors WHA Resolution on Rare Diseases
Rare Diseases International applauds the Arab Republic of Egypt for sponsoring a resolution entitled “Rare Diseases: A Priority for Global Health Equity and Inclusion” at the World Health Assembly (WHA) 78, to be held in May 2025.
The 300 million Persons Living with a Rare Disease (PLWRD) globally continue to face challenges including delays in diagnosis, limited access to treatments and care, and financial burdens. While many regions and countries have made commendable progress in addressing these challenges, progress has not been consistent across all communities. To systemically and sustainably improve the rare disease ecosystem, collective action through a collaborative and multisectoral approach is crucial. To ensure that UHC indeed entails “health for all”, rare diseases need to be made a global health priority.
This WHA Resolution on Rare Diseases will aim to address the challenges facing the rare disease community through a comprehensive global framework that includes raising awareness, improving diagnosis, enhancing access to care and treatment, and fostering research and development of therapies.
RDI now calls upon Member States to join Egypt in cosponsoring this initiative. By adopting a WHA resolution on rare diseases, Member States can strengthen their positions as leaders in healthcare innovation, cement their commitment to health equity and inclusion, and contribute their respective expertise and resources to improve the lives of PLWRD not only nationally, but globally.
The WHA resolution, and ideally the resulting global action plan, will be the catalyst that urges Member States to work together towards enhancing policy processes, advancing research, accelerating innovation, and improving access to care for PLWRD worldwide, and to ensure that PLWRD are included in the critical work being done to advance UHC and inclusion across the globe.